Skip to main content
. 2014 May 16;3(3):e000732. doi: 10.1161/JAHA.113.000732

Figure 1.

Figure 1.

Association of Hp genotype with cardiovascular disease (CVD) risk by glycosylated hemoglobin (HbA1c) level under progressive adjustment. No. of person‐years of follow‐up/cases was 9250/102 for subjects with HbA1c<6.5% (4323/50 in the Hp 2‐2 and 4927/52 in the Hp 2‐1/1‐1 group) and 613/21 for subjects with HbA1c≥6.5% (375/8 in the Hp 2‐2 and 238/13 in the Hp 2‐1/1‐1 group). Model 1 was adjusted for age and sex, model 2 additionally for current smoking, systolic blood pressure, LDL cholesterol, and HDL cholesterol, and model 3 additionally for metabolic equivalent hours, alternative healthy eating index, statin use, and body mass index. HbA1c indicates glycosylated hemoglobin; HDL, high‐density lipoprotein cholesterol; LDL, low‐density lipoprotein cholesterol.